|  | Webinar: COVID-19 Virus Sequencing for Drug Development Wednesday, July 28 | 10:30am ET / 7:30am PT As new COVID-19 variants continue to emerge, virus sequencing will play critical and ongoing role in drug and vaccine development. This webinar will connect insights from population surveillance to potential solutions for drug developers, outline approaches to COVID-19 virus sequencing and more. Register Now. |
Featured Story | By Nick Paul Taylor The U.K. has vowed to deepen its expertise in vaccine formulation and delivery as part of its vision for the life sciences industry. Government officials want to support a move away from injections and toward delivery of vaccines via the mouth, skin and nose. read more |
| |
|---|
|
Top Stories By Fraiser Kansteiner A little over a week after striking an $813 million deal for oral drug delivery company Fertin Pharma, Marlboro maker Philip Morris International is doubling down on its pharma ambitions with plans to snap up inhalation-specialist-turned-CDMO Vectura. read more By Angus Liu Incyte’s ruxolitinib cream was among a group of JAK inhibitors to have their applications held up at the FDA thanks to a heart safety problem for Pfizer’s Xeljanz. But after surveying doctors, one group of analysts believes the topical atopic dermatitis candidate can be a competitive player. read more By Nick Paul Taylor Ena Respiratory has begun a phase 1 clinical trial of its nasal spray for the prevention of COVID-19 and other respiratory viral infections. The study is expected to wrap up in the third quarter. read more By Nick Paul Taylor A clinical trial has found nasal nalmefene delivery achieves significantly higher plasma concentrations than intramuscular injections, advancing Opiant Pharmaceuticals’ hopes of filing for approval around the end of the year. read more By Nick Paul Taylor Fresenius Kabi has added a fentanyl product to its range of ready-to-administer prefilled syringe. The 1-mL presentation, which Fresenius said is unique on the U.S. market, is designed to cut waste and diversion by reducing the potential for errors. read more |  | Whitepaper: DNA-Encoded Library - Advancing Innovative Drug Discovery Since its concept was conceived in 1992, DNA-encoded libraries (DELs) have evolved into a valuable technology for hit identification in drug discovery. This whitepaper provides a better understanding of DEL technology and stimulate innovation in the field by describing the DEL design, synthesis, screening and expanded applications. Learn More. |
Resources Sponsored by: Patheon by Thermo Fisher Scientific Take a closer look at your supply chain to ensure it delivers with speed, efficiency, and quality — all within budget. Sponsored by: Patheon by Thermo Fisher Scientific Take a closer look at your supply chain to ensure it delivers with speed, efficiency, and quality — all within budget. Sponsored by: Patheon by Thermo Fisher Scientific Choose the right AAV platform for your viral vector-based therapy Sponsored by: Blue Matter Consulting E-book to get newcomers “up to speed” quickly on digital health and digital therapeutics while also addressing key issues important to those already familiar with the topic. Sponsored by: WCG Engage Independent Expert Endpoint Adjudication and Data Monitoring Committees in a strategic manner to identify methods for retrospective and prospective evaluations that may improve competitive advantage and bolster regulatory submissions. Sponsored by: PA Consulting What does the future of Cell & Gene Therapy look like? Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process intesification Sponsored by: Cytiva A one-stop hub for Cytiva resources to support process development and manufacturing of your novel molecule Sponsored By: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. Sponsored By: Within3 We enable virtual work — offering over-time sessions where participants are more focused, insights are more diverse and business goals are met. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. | 
